Wisdomtree Biorevolution Etf Profile

WDNA Etf  USD 15.08  0.11  0.73%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
WisdomTree BioRevolution is trading at 15.08 as of the 21st of November 2024, a 0.73 percent increase since the beginning of the trading day. The etf's open price was 14.97. WisdomTree BioRevolution has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for WisdomTree BioRevolution are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of August 2024 and ending today, the 21st of November 2024. Click here to learn more.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. More on WisdomTree BioRevolution

Moving together with WisdomTree Etf

  0.78XLV Health Care SelectPairCorr
  0.79VHT Vanguard Health CarePairCorr
  0.93IBB iShares Biotechnology ETFPairCorr
  0.76IXJ iShares Global HealthcarePairCorr

Moving against WisdomTree Etf

  0.69STCE Schwab Strategic TrustPairCorr
  0.58EOS Eaton Vance EnhancedPairCorr
  0.48VBK Vanguard Small CapPairCorr
  0.4XOP SPDR SP OilPairCorr
  0.33EVUS iShares ESG AwarePairCorr

WisdomTree Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationStrategy ETFs, Theme ETFs, Health, WisdomTree (View all Sectors)
IssuerWisdomTree
Inception Date2021-06-03
BenchmarkWisdomTree BioRevolution Index
Entity TypeRegulated Investment Company
Asset Under Management2.26 Million
Asset TypeEquity
CategoryStrategy
FocusTheme
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorState Street Bank and Trust Company
AdvisorWisdomTree Asset Management, Inc
CustodianState Street Bank and Trust Company
DistributorForeside Fund Services, LLC
Portfolio ManagerMarlene Walker-Smith, Thomas J. Durante
Transfer AgentState Street Bank and Trust Company
Fiscal Year End30-Jun
ExchangeCboe BZX Exchange, Inc.
Number of Constituents100.0
Market MakerFlow Traders
Total Expense0.45
Management Fee0.45
Country NameUSA
Returns Y T D(11.25)
NameWisdomTree BioRevolution Fund
Currency CodeUSD
Open FigiBBG0119987C0
In Threey Volatility23.17
1y Volatility25.51
200 Day M A16.3167
50 Day M A16.1056
CodeWDNA
Updated At20th of November 2024
Currency NameUS Dollar
In Threey Sharp Ratio(0.75)
WisdomTree BioRevolution [WDNA] is traded in USA and was established 2021-06-01. The fund is listed under Health category and is part of WisdomTree family. The entity is thematically classified as Strategy ETFs. WisdomTree BioRevolution at this time have 4.54 M in net assets. , while the total return for the last 3 years was -15.2%.
Check WisdomTree BioRevolution Probability Of Bankruptcy

Geographic Allocation (%)

WisdomTree BioRevolution Currency Exposure

WisdomTree BioRevolution holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of WisdomTree BioRevolution will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in WisdomTree BioRevolution.

Top WisdomTree BioRevolution Etf Constituents

AAgilent TechnologiesStockHealth Care
AGENAgenus IncStockHealth Care
BIIBBiogen IncStockHealth Care
DHRDanaherStockHealth Care
EDITEditas MedicineStockHealth Care
ILMNIlluminaStockHealth Care
LLYEli Lilly andStockHealth Care
PKIPerkinElmerStockHealth Care
More Details

WisdomTree BioRevolution Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in WisdomTree BioRevolution. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

WisdomTree BioRevolution Against Markets

When determining whether WisdomTree BioRevolution offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of WisdomTree BioRevolution's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Wisdomtree Biorevolution Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Wisdomtree Biorevolution Etf:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WisdomTree BioRevolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
The market value of WisdomTree BioRevolution is measured differently than its book value, which is the value of WisdomTree that is recorded on the company's balance sheet. Investors also form their own opinion of WisdomTree BioRevolution's value that differs from its market value or its book value, called intrinsic value, which is WisdomTree BioRevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WisdomTree BioRevolution's market value can be influenced by many factors that don't directly affect WisdomTree BioRevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WisdomTree BioRevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.